Entry Detail



General Information

Database ID:exR0080348
RNA Name:RHOA
RNA Type:mRNA
Chromosome:chr3
Starnd:-
Coordinate:
Start Site(bp):49359145End Site(bp):49412998
External Links:ENSG00000067560



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC012254.2
chr18
47108188
47176345
-
AL603832.3
chr1
112702614
112711433
-
AKAP9
chr7
91940867
92110673
+
AC010422.3
chr19
12643831
12648397
-
AC008982.1
chr19
38817471
38840178
-
AC087289.3
chr17
75898645
75930129
-
AL928654.3
chr14
105487199
105492267
+
AC023055.1
chr12
55757275
55827546
-
ABCE1
chr4
145098288
145129524
+
ADIPOR1
chr1
202940826
202958572
-
ADAM10
chr15
58588809
58749791
-
ACAT2
chr6
159762045
159779112
+
AL022238.4
chr22
40346529
40410054
+
AC007192.1
chr19
18153158
18178117
+
AHCY
chr20
34280268
34311802
-
AC008763.3
chr19
7678501
7682854
+
ACTB
chr7
5527148
5563784
-
ADSL
chr22
40346500
40390463
+
ABHD14B
chr3
51968510
51983409
-
ACACA
chr17
37084992
37406836
-
ACIN1
chr14
23058564
23095614
-
ACTG1
chr17
81509971
81523847
-
AL590764.2
chrX
71103987
71111575
-
AC135050.2
chr16
31083439
31094956
-
ADNP2
chr18
80109262
80147523
+
AC245033.1
chr15
82536788
82573194
-
ACTL6A
chr3
179562886
179588407
+
AC027796.3
chr17
3585149
3636249
-
ADCY1
chr7
45574140
45723116
+
AK2
chr1
33007940
33080996
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-122-5p
chr18
58451088
58451109
+
hsa-miR-130b-3p
chr22
21653354
21653375
+
hsa-miR-454-3p
chr17
59137787
59137809
-
hsa-miR-1244
chr2
231713368
231713393
+
hsa-miR-4284
chr7
73711327
73711344
+
hsa-miR-4492
chr11
118910765
118910781
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005062.1
chr7
19918981
20140453
-
AC007952.4
chr17
19112000
19112636
-
AC023509.1
chr12
53441741
53467528
+
AC073050.1
chr2
167293171
167558333
+
AC093227.1
chr19
37728586
37730643
-
AC245033.4
chr15
82533175
82540008
-
AL022311.1
chr22
37876148
37895563
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA